Registry of Lobbyists
| Organization: | Heart and Stroke Foundation of Canada/Fondation des maladies du coeur et de l’AVC |
| Associated registration: | 946004-119-56 |
| Communication date: | 2022-10-06 |
| Posted date: | 2022-11-15 |
| Designated Public Office Holders who participated in the communication: |
Brent Lawlor,
Acting Director
Canada Drug Agency Transition Office, Health Canada (HC) Michelle Bourdreau, Executive Director Office of Pharmaceutical Management Strategies, Health Canada (HC) Jennifer Boutin, Senior Policy Analyst Canada Drug Agency Transition Office, Health Canada (HC) Margaret Sharp, Director - Pharmacy Office of Pharmaceutical Management Strategies, Health Canada (HC) Bobby Chauhan, Director - Engagement Office of Pharmaceutical Management Strategies, Health Canada (HC) |
| Subject Matter of the communication: | Health |
| Responsible Officer who filed this communication report: | Doug Roth |
| As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed. | |